E
KRMD icon

Ergoteles’s KORU Medical Systems KRMD Stock Holding History

Ergoteles’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-116,123
Closed -$331K – 1428
2021
Q3 		$331K Sell
116,123
-7,177
-6% -$23.7K 0.01% 759
2021
Q2 		$571K Buy
+123,300
New +$484K 0.01% 744

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's KRMD Position: Q4 2021 in Review

Ergoteles sold out of KORU Medical Systems (KRMD) in Q4 2021, closing a stake of 116,123 shares — an estimated $331K sold.

Ergoteles first reported a position in KRMD in Q2 2021 and held it in 2 quarters. The position peaked at $571K in Q2 2021. 44 funds tracked by Wall St. Rank hold KRMD as of Q4 2021.

  • Ergoteles reported no remaining KORU Medical Systems position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 116,123 KORU Medical Systems shares in Q4 2021, an estimated $331K.
  • Ergoteles first reported a position in KORU Medical Systems in Q2 2021 and held it in 2 quarters.
  • Ergoteles's KORU Medical Systems position peaked at $571K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held KORU Medical Systems as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.